185 related articles for article (PubMed ID: 14725621)
1. The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin.
Rangone H; Poizat G; Troncoso J; Ross CA; MacDonald ME; Saudou F; Humbert S
Eur J Neurosci; 2004 Jan; 19(2):273-9. PubMed ID: 14725621
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421.
Pardo R; Colin E; Régulier E; Aebischer P; Déglon N; Humbert S; Saudou F
J Neurosci; 2006 Feb; 26(5):1635-45. PubMed ID: 16452687
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of arfaptin 2 at Ser260 by Akt Inhibits PolyQ-huntingtin-induced toxicity by rescuing proteasome impairment.
Rangone H; Pardo R; Colin E; Girault JA; Saudou F; Humbert S
J Biol Chem; 2005 Jun; 280(23):22021-8. PubMed ID: 15809304
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons.
Anne SL; Saudou F; Humbert S
J Neurosci; 2007 Jul; 27(27):7318-28. PubMed ID: 17611284
[TBL] [Abstract][Full Text] [Related]
5. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.
Humbert S; Bryson EA; Cordelières FP; Connors NC; Datta SR; Finkbeiner S; Greenberg ME; Saudou F
Dev Cell; 2002 Jun; 2(6):831-7. PubMed ID: 12062094
[TBL] [Abstract][Full Text] [Related]
6. [Huntington's disease: intracellular signaling pathways and neuronal death].
Humbert S; Saudou F
J Soc Biol; 2005; 199(3):247-51. PubMed ID: 16471265
[TBL] [Abstract][Full Text] [Related]
7. Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease.
Ho LW; Brown R; Maxwell M; Wyttenbach A; Rubinsztein DC
J Med Genet; 2001 Jul; 38(7):450-2. PubMed ID: 11432963
[TBL] [Abstract][Full Text] [Related]
8. IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux.
Lee H; Noh JY; Oh Y; Kim Y; Chang JW; Chung CW; Lee ST; Kim M; Ryu H; Jung YK
Hum Mol Genet; 2012 Jan; 21(1):101-14. PubMed ID: 21954231
[TBL] [Abstract][Full Text] [Related]
9. Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity.
Apostol BL; Illes K; Pallos J; Bodai L; Wu J; Strand A; Schweitzer ES; Olson JM; Kazantsev A; Marsh JL; Thompson LM
Hum Mol Genet; 2006 Jan; 15(2):273-85. PubMed ID: 16330479
[TBL] [Abstract][Full Text] [Related]
10. Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity.
Luo S; Vacher C; Davies JE; Rubinsztein DC
J Cell Biol; 2005 May; 169(4):647-56. PubMed ID: 15911879
[TBL] [Abstract][Full Text] [Related]
11. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
Apostol BL; Simmons DA; Zuccato C; Illes K; Pallos J; Casale M; Conforti P; Ramos C; Roarke M; Kathuria S; Cattaneo E; Marsh JL; Thompson LM
Mol Cell Neurosci; 2008 Sep; 39(1):8-20. PubMed ID: 18602275
[TBL] [Abstract][Full Text] [Related]
12. Implication of the JNK pathway in a rat model of Huntington's disease.
Perrin V; Dufour N; Raoul C; Hassig R; Brouillet E; Aebischer P; Luthi-Carter R; Déglon N
Exp Neurol; 2009 Jan; 215(1):191-200. PubMed ID: 19022249
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of huntingtin reduces the accumulation of its nuclear fragments.
Warby SC; Doty CN; Graham RK; Shively J; Singaraja RR; Hayden MR
Mol Cell Neurosci; 2009 Feb; 40(2):121-7. PubMed ID: 18992820
[TBL] [Abstract][Full Text] [Related]
14. Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2.
Kobayashi T; Cohen P
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):319-28. PubMed ID: 10191262
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons.
Zala D; Colin E; Rangone H; Liot G; Humbert S; Saudou F
Hum Mol Genet; 2008 Dec; 17(24):3837-46. PubMed ID: 18772195
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the nuclear matrix protein NAKAP with HypA and huntingtin: implications for nuclear toxicity in Huntington's disease pathogenesis.
Sayer JA; Manczak M; Akileswaran L; Reddy PH; Coghlan VM
Neuromolecular Med; 2005; 7(4):297-310. PubMed ID: 16391387
[TBL] [Abstract][Full Text] [Related]
17. Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin.
Jiang H; Poirier MA; Liang Y; Pei Z; Weiskittel CE; Smith WW; DeFranco DB; Ross CA
Neurobiol Dis; 2006 Sep; 23(3):543-51. PubMed ID: 16766198
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia.
Tower C; Fu L; Gill R; Prichard M; Lesort M; Sztul E
Neurobiol Dis; 2011 Jan; 41(1):11-22. PubMed ID: 20732421
[TBL] [Abstract][Full Text] [Related]
19. Impaired basal and running-induced hippocampal neurogenesis coincides with reduced Akt signaling in adult R6/1 HD mice.
Ransome MI; Hannan AJ
Mol Cell Neurosci; 2013 May; 54():93-107. PubMed ID: 23384443
[TBL] [Abstract][Full Text] [Related]
20. Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.
Naia L; Ferreira IL; Cunha-Oliveira T; Duarte AI; Ribeiro M; Rosenstock TR; Laço MN; Ribeiro MJ; Oliveira CR; Saudou F; Humbert S; Rego AC
Mol Neurobiol; 2015 Feb; 51(1):331-48. PubMed ID: 24841383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
